Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetBile acid receptor
LigandBDBM50336403
Substrate/Competitorn/a
Meas. Tech.ChEMBL_716784 (CHEMBL1670706)
IC50 3900±n/a nM
Citation Richter, HGBenson, GMBleicher, KHBlum, DChaput, EClemann, NFeng, SGardes, CGrether, UHartman, PKuhn, BMartin, REPlancher, JMRudolph, MGSchuler, FTaylor, S Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties. Bioorg Med Chem Lett21:1134-40 (2011) [PubMed]  Article
More Info.:Get all data from this article,  Assay Method
 
Bile acid receptor
Name:Bile acid receptor
Synonyms:BAR | Bile acid receptor FXR | FXR | Farnesol receptor HRR-1 | HRR1 | NR1H4 | NR1H4_HUMAN | Nuclear receptor subfamily 1 group H member 4 | RIP14 | RXR-interacting protein 14 | Retinoid X receptor-interacting protein 14 | farnesoid x receptor
Type:Nuclear Receptor
Mol. Mass.:55916.24
Organism:Homo sapiens (Human)
Description:Q96RI1
Residue:486
Sequence:
MVMQFQGLENPIQISPHCSCTPSGFFMEMMSMKPAKGVLTEQVAGPLGQNLEVEPYSQYS
NVQFPQVQPQISSSSYYSNLGFYPQQPEEWYSPGIYELRRMPAETLYQGETEVAEMPVTK
KPRMGASAGRIKGDELCVVCGDRASGYHYNALTCEGCKGFFRRSITKNAVYKCKNGGNCV
MDMYMRRKCQECRLRKCKEMGMLAECMYTGLLTEIQCKSKRLRKNVKQHADQTVNEDSEG
RDLRQVTSTTKSCREKTELTPDQQTLLHFIMDSYNKQRMPQEITNKILKEEFSAEENFLI
LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSD
LLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEK
LQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVNDHKFTPLLC
EIWDVQ
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50336403
n/a
NameBDBM50336403
Synonyms:CHEMBL1668250 | trans-4-(((S)-2-(2-(4-chlorophenyl)-5,6-difluoro-1H-benzo[d]imidazol-1-yl)-2-cyclohexylacetamido)methyl)cyclohexanecarboxylic acid
TypeSmall organic molecule
Emp. Form.C29H32ClF2N3O3
Mol. Mass.544.032
SMILESOC(=O)[C@H]1CC[C@H](CNC(=O)[C@H](C2CCCCC2)n2c(nc3cc(F)c(F)cc23)-c2ccc(Cl)cc2)CC1 |r,wU:11.18,6.6,wD:3.2,(-6.64,-8.02,;-5.3,-7.27,;-3.97,-8.05,;-5.29,-5.72,;-3.94,-4.96,;-3.93,-3.42,;-5.25,-2.65,;-5.24,-1.11,;-3.9,-.35,;-2.58,-1.13,;-2.59,-2.67,;-1.24,-.37,;.09,-1.15,;.07,-2.68,;1.39,-3.46,;2.73,-2.71,;2.75,-1.17,;1.42,-.38,;-1.23,1.17,;-.32,2.43,;-1.24,3.68,;-2.71,3.2,;-4.05,3.96,;-5.38,3.19,;-6.71,3.96,;-5.38,1.64,;-6.71,.88,;-4.04,.87,;-2.7,1.64,;1.22,2.45,;1.99,1.12,;3.53,1.13,;4.29,2.46,;5.83,2.48,;3.51,3.8,;1.97,3.78,;-6.6,-3.4,;-6.61,-4.93,)|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: